Palmer: PRV-031 could be first ever disease modifying type 1 diabetes therapy
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Researchers Discover a Breakthrough Drug That May Significantly Delay Type 1 Diabetes
A monoclonal antibody called teplizumab has been shown to delay the onset of type 1 diabetes for as long as two years. About 1.25 million Americans suffer from the disease, a form of diabetes in........»»
Researcher one step closer to halting type 1 diabetes in kids
Researchers at Massachusetts General Hospital have been studying a generic drug that's shown potential to cure type 1 diabetes in adults. Now, researchers want to test the same drug in children with the disease. Dr. Denise Faustman, director of the Mas.....»»
A new theory on why sleeping less than 7 hours per night can lead to heart disease and Type 2 diabetes
Decades of research has shown that chronic short sleep is associated with increased risk of clogged arteries, heart disease, and early mortality......»»
Why sleeping less than 7 hours can lead to heart disease and Type 2 diabetes
Decades of research has shown that chronic short sleep is associated with increased risk of clogged arteries, heart disease, and early mortality......»»
23andMe eyes millions of more users with new report on diabetes
23andMe is adding a report to its health and ancestry DNA test for type 2 diabetes. That's a huge market opportunity as 1 in 3 people are at risk for developing the disease. More than 30 million people in the U.S. alone have diabetes......»»
6 simple, science-backed ways to get rid of belly fat
Shutterstock/ nd3000 Having lots of fat in the abdominal area is strongly linked to diseases like type 2 diabetes and heart disease. Excess sugar and carb consumptio.....»»
Valeritas V-Go demonstrates benefits compared to MDI therapy for type 2 diabetes
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Eli Lilly"s Tirzepatide Non-Inferior To Titrated Insulin Glargine In Type 2 Diabetes Patients
read more.....»»
Biogen"s Retinal Disease Gene Therapy Flunks Mid-Stage Study
Biogen Inc (NASDAQ: BIIB) has announced topline results from the Phase 2/3 XIRIUS study evaluating cotoretigene toliparvovec (BIIB112), a gene therapy being investigated as a one-time therapy for patients w.....»»
Biogen"s Retinal Disease Gene Therapy Flunks Mid-Stage Study
read more.....»»
Peninsula gene therapy company"s stock sinks 50% after-hours on serious side effect in eye trial
The company already is in a bitter proxy fight with a hedge fund that claims its board has provided weak oversight of management as it allegedly ignores a side effect of its gene therapy against a blinding eye disease......»»
Vertex to study experimental gene-editing therapy as treatment for sickle cell, beta-thalassemia
Vertex Pharmaceuticals Inc. said Tuesday it plans to pay $1.1 billion to Crispr Therapeutics AG as part of a deal to test an experimental gene-editing therapy for sickle cell disease and transfusion-dependent beta-tha.....»»
Moleculin Biotech Stock Is Trading Higher After WP1066 Scores Rare Pediatric Disease Tag For Type Of Brain Tumor
read more.....»»
Vertex to begin Phase 1/2 trial of treatment for people with type 1 diabetes
Shares of Vertex Pharmaceuticals Inc. were down 0.2% in trading on Wednesday after the company said it started an early-stage clinical t.....»»
Inovio spinout Geneos closes $12M financing round to advance personalized cancer therapy
The Montgomery County biopharmaceutical company's initial target is a type of liver cancer known as advanced hepatocellular carcinoma......»»
Provention Bio"s teplizumab shows efficacy in delaying type 1 diabetes
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Takeda to divest type 2 diabetes portfolio to Teijin Pharma for JPY 133B
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Eli Lilly"s Tirzepatide Reduces A1C And Body Weight, Late-Stage Studies In Type 2 Diabetes Show
read more.....»»
Freeline to highlight data from Gaucher and Fabry disease gene therapy program
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Amicus announces preclinical Fabry disease gene therapy data
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»